Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Impact of Neutrophil Extracellular Traps and Low Density Neutrophils in Primary Graft Dysfunction following Human Lung Transplantation

EF 2020-21

Résumé
Neutrophils, which are the main immune cells in the blood, play a significant role in complications associated to human lung transplant. These cells, classified in two subtypes as high-density (HDNs) and low-density neutrophils (LDNs), can be activated by various factors both in donors and recipients. About 30% of lung recipients develop life-threatening complications due to dysregulation of their freshly transplanted lungs. Recently, neutrophils were found to produce web-like structures in blood, termed Neutrophil Extracellular Traps (NETs), leading to the blockage of blood vessels and inflammation. Thus, we hypothesize that NETs, primarily produced by LDNs, are responsible of blood vessels blockage in grafted lungs, leading to severe pulmonary inflammation, dysfunction and subsequent recipient death. In order to explore the role of NETs and LDNs in complications following lung transplant, blood samples are taken from the donors and recipients prior, during and after surgery. With the blood samples, isolation of neutrophil subtypes followed by quantification of NETs and associated inflammatory mediators is done to follow the dynamics of NETs production and inflammation within the patients. When possible, we also sample lung tissue to be grafted for the visualization of NETs and vascular blockage. Our preliminary data are highly supportive of a major role of NETs in postoperative complications. The potential benefits of our research can be significant considering that a treatment exists to degrade NETs. This treatment (DNase I, also termed Pulmozyme) is already used for cystic fibrosis and could readily be available for lung transplant. In short term, we may have a life-saving and low-cost therapeutic approach to help a great number of heavily harmed lung recipients.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
449422
Name
Dasilva Ariane
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Impact of Neutrophil Extracellular Traps and Low Density Neutrophils in Primary Graft Dysfunction following Human Lung Transplantation
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chronic Obstructive Pulmonary Disease; Cystic Fibrosis; Idiopathic Pulmonary Fibrosis; Inflammation; Interstitial Lung Diseases; Lung Transplantation; Neutrophil Extracellular Traps; Neutrophils; Pulmonary Hypertension; Surgery
Abstract
Neutrophils, which are the main immune cells in the blood, play a significant role in complications associated to human lung transplant. These cells, classified in two subtypes as high-density (HDNs) and low-density neutrophils (LDNs), can be activated by various factors both in donors and recipients. About 30% of lung recipients develop life-threatening complications due to dysregulation of their freshly transplanted lungs. Recently, neutrophils were found to produce web-like structures in blood, termed Neutrophil Extracellular Traps (NETs), leading to the blockage of blood vessels and inflammation. Thus, we hypothesize that NETs, primarily produced by LDNs, are responsible of blood vessels blockage in grafted lungs, leading to severe pulmonary inflammation, dysfunction and subsequent recipient death. In order to explore the role of NETs and LDNs in complications following lung transplant, blood samples are taken from the donors and recipients prior, during and after surgery. With the blood samples, isolation of neutrophil subtypes followed by quantification of NETs and associated inflammatory mediators is done to follow the dynamics of NETs production and inflammation within the patients. When possible, we also sample lung tissue to be grafted for the visualization of NETs and vascular blockage. Our preliminary data are highly supportive of a major role of NETs in postoperative complications. The potential benefits of our research can be significant considering that a treatment exists to degrade NETs. This treatment (DNase I, also termed Pulmozyme) is already used for cystic fibrosis and could readily be available for lung transplant. In short term, we may have a life-saving and low-cost therapeutic approach to help a great number of heavily harmed lung recipients.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dasilva, Ariane
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~